Nathanael Fillmore

Assistant Professor of Medicine

Harvard Medical School

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nathanael Fillmore is an Assistant Professor of Medicine at Harvard Medical School. His research focuses on the intersection of oncology and mental health, with recent publications examining predictors of outcomes in cancer patients, particularly veterans. His notable studies include the impact of psychiatric disorders on acute myeloid leukemia and the implications of lymphopenia and frailty in multiple myeloma patients. He is also involved in research on immune-related adverse events and SARS-CoV-2 complications in individuals with plasma cell disorders.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

Augusta University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nathanael Fillmore

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia

Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma

Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy

Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients

Baseline correlates of frailty and its association with survival in United States veterans with acute myeloid leukemia

Even after SARS-CoV-2 Booster There is Increased COVID-19 Breakthrough Infection in Patients with Plasma Cell Disorders

Allostatic load and cardiovascular outcomes in males with prostate cancer.

Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma.

Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.

Sentiment analysis of medical record notes for lung cancer patients at the Department of Veterans Affairs.

Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigation.

The COVID-19 hospitalization metric in the pre- and postvaccination eras as a measure of pandemic severity: A retrospective, nationwide cohort study

Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System.

Collaborators (5)

Jerry Lee

Apar Kishor Ganti

Camille V Edwards

Hamza Hassan

Biplab Datta

Make your next move.